These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7872962)

  • 1. Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines.
    Pizzorno G; Handschumacher RE
    Biochem Pharmacol; 1995 Feb; 49(4):559-65. PubMed ID: 7872962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
    J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
    Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
    Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil.
    Pizzorno G; Sun Z; Handschumacher RE
    Biochem Pharmacol; 1995 Feb; 49(4):553-7. PubMed ID: 7872961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
    Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
    Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
    Schwartz PM; Moir RD; Hyde CM; Turek PJ; Handschumacher RE
    Biochem Pharmacol; 1985 Oct; 34(19):3585-9. PubMed ID: 2996553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.
    Sobrero A; Aschele C; Guglielmi A; Nobile MT; Rosso R
    J Chemother; 1990 Feb; 2 Suppl 1():12-6. PubMed ID: 2142213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Grem JL; Allegra CJ
    Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinoma, and xenografts.
    Ahmed NK
    Cancer; 1984 Oct; 54(7):1370-3. PubMed ID: 6088027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues].
    Uchida M; Kamiya K; Yoshimura T; Sasaki K; Tsutani H; Nakamura T; Ho DH
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):990-6. PubMed ID: 2167917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL; Fischer PH
    Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
    Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
    Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.
    Tezuka M; Sugiyama H; Tamemasa O; Inaba M
    Gan; 1982 Feb; 73(1):70-6. PubMed ID: 7117749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.